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Abstrac t  
Aim: To assess functional effects of silica nanoparticles (SiO2-NPs) on human mesenchymal 
stem cell (hMSC) cardiac integration potential.  
Methods: SiO2-NPs were synthesized and their internalization effects on hMSCs analyzed 
with particular emphasis on interaction of hMSCs with the cardiac environment  
Results:SiO2-NP internalization affected the area and maturation level of hMSC focal 
adhesions, accounting for increased in vitro adhesion capacity and augmented engraftment in 
the myocardial tissue upon cell injection in infarcted isolated rat hearts. SiO2-NP treatment also 
enhanced hMSC expression of Connexin-43, favoring hMSC interaction with cocultured 
cardiac myoblasts in an ischemia-like environment.  
Conclusion: These findings provide strong evidence that SiO2-NPs actively engage in 
mediating biological effects, ultimately resulting in augmented hMSC acute cardiac integration 
potential. 
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Human mesenchymal stem cells (hMSCs) represent an attractive therapeutic source as they 
appear to have beneficial effects in regenerating injured tissues [1], including the cardiac 
tissue [2,3]. 
Although both preclinical and clinical studies suggest the therapeutic potential of hMSCs, 
several questions remain open. An important limitation of hMSCs is the low survival rate within 
the first 1–2 weeks after transplantation, due to anoikis in damaged tissues [4]. Anoikis is a 
programmed cell death that occurs in anchorage-dependent cells when they detach from the 
extracellular matrix (ECM) [5,6]. Indeed, a loss of matrix anchorage and a subsequent low 
propensity to adhere may cause the anoikis of the transplanted MSCs. Therefore, to enhance 
cell survival in the site of transplantation, one should enhance the adhesion of the transplanted 
MSCs to limit anoikis. This might improve the success of the MSC-based therapeutic 
approach. Although a number of studies aim to improve MSC survival at the site of 
transplantation, yet few effective solutions have been proposed to solve the problem of weak 
cell-ECM adhesion [7,8]. 
In the context of stem cell transplantation, another crucial aspect is the capability of hMSCs to 
correctly interact with the surrounding cells in the injured tissue. In the context of myocardium 
regeneration, cross-talk between cardiomyocyte and hMSCs represents the key point for 
paracrine factors exchange: protective factors released by hMSCs and factors released by 
cardiomyocyte may affect the fate of cell transplantation [9]. The possibility to form functional 
gap junctions allows the connection of the cytoplasm of adjacent cells. This will permit various 
small molecules, including ions and secondary messengers, to directly pass through a 
regulated gate between cells and this may be a modality for MSCs to exert cytoprotective 
effects [10]. It has been demonstrated that hMSCs express cardiac connexins, the building 
block proteins of gap junctions, and can form functional gap junctions with other cells 
expressing cardiac connexins including adult cardiac myocytes [11]. Therefore, the ability to 
increase connexin expression in MSCs would be critical to promoting cardiac regeneration. 
Nanoparticle (NP)-based stem cell imaging has emerged as an essential tool for regenerative 
medicine, in order to track the MSCs and document both their persistence and promotion of 
regenerative effects [12–14]. Up to now, however, there are only a few reports on the effects 
exerted on MSC functions by cellular uptake of different NP types [14,15], even though this 
would be of great interest for the design of high-performance NP-based imaging systems for 
regenerative medicine processes. We have developed a method of fluorescent staining with 
silica NPs (SiO2-NPs) suited to track hMSCs and validated this approach both in vitro [16,17] 
and ex vivo [18]. We already demonstrated that SiO2-NP uptake by hMSCs was well tolerated 
in the long term, did induce neither cell death nor genotoxic stress and did not alter 
proliferative activity and differentiation potential of hMSCs [16–18]. 
In order to extend the use of SiO2-NPs in cardiac regenerative medicine in vivo, it is of great 
interest to point out any possible stem cell responses to this nanomaterial internalization. 
Thus, the aim of the present work was to evaluate whether any phenotypic effects could be 
exerted by internalization of SiO2-NPs that might ultimately impact on hMSC regenerative 
potential, with particular emphasis on the interaction of hMSCs with the cardiac environment. 
Materials & methods 
SiO2-NPs: production, size & photoemission properties 
Pure SiO2-NPs and red fluorescent cyanine dye-doped SiO2-NPs were prepared exploiting 
reverse micelles formed in a water-in-oil microemulsion, as detailed by Alberto et al. [19]. For 
the preparation of dye-doped nanoparticles, the aminopropyltrietoxysilane derivative of IRIS3 
cyanine (by Pianeta Srl, formerly Cyanine Technologies Srl, Torino, Italy) was added to the 
reaction system. The absorption and photoluminescence spectra of IRIS 3 range from ca. 450 
to 575 nm and from 500 to 700 nm, respectively. At the end of the process cyanine molecules 
resulted stably entrapped in the bulk of NPs based on solvatochromism test, thus the surface 
chemistry of NPs was not affected by the presence of IRIS3 molecules. Obtained SiO2-NPs 
(both pure and dye-doped) exhibited a diameter of 50 ± 2 nm and possessed elevated 
morphologic homogeneity. When containing cyanine molecules, they displayed bright 
fluorescence emission and high photostability [19,20]. 
SiO2-NP characterization 
Dynamic light scattering 
Dynamic light scattering measurements were performed in a 90Plus Particle Size Analyzer 
(Brookhaven Instruments, NY, USA) at a laser wavelength of 660 nm and a detection angle of 
90 degrees at 293 K. Samples were prepared by suspending for up to 1 h SiO2-NPs in distilled 
water (pH 5.5) and DMEM 1% fetal bovine serum (FBS). In all cases the SiO2-NPs 
concentration just before measurements was 20 μg/ml. Dynamic light scattering plots are 
reported as mass distribution. Measurements were performed in triplicates. 
ζ-potential 
The surface potential of both bare SiO2-NPs (suspended for 1 h in distilled water and in 
DMEM) and SiO2-NPs with hard corona proteins (suspended for 1 h in DMEM) was evaluated 
by electrophoretic light scattering using a Zetasizer Nano-ZS, Malvern Instruments 
(Worcestershire, UK). SiO2-NPs with the protein hard corona were obtained by the FBS 
adsorption procedure reported in the Supplementary Materialsdocument, with final washing in 
DMEM. 
Cell culture & drug treatments 
hMSCs isolated from the bone marrow of healthy donors were commercially obtained from 
Lonza (Lonza Group Ltd, Switzerland). For all the experiments cells from passage 4 to 8 were 
used. Briefly, hMSCs were cultured in DMEM supplemented with 1% sodium pyruvate, 1% 
nonessential amino acids, 1% kanamycin, 1% L-glutamine, 0.1% β-mercaptoethanol 
(complete DMEM) and 10% FBS (standard medium) (all from Sigma-Aldrich, MO, USA) and 
kept in an atmosphere of 5% CO2, 95% air at 37°C in a humidified incubator. Cells were 
expanded at a seeding density of 3500 cell/cm2 and subcultured twice a week. Exponentially 
growing hMSCs were seeded at 6,500 cell/cm2 24 h before the two following protocols: SiO2-
NPs: cells were exposed for 16 h to a suspension of water dissolved SiO2-NPs 50 μg/ml in 
complete DMEM 1% FBS; SiO2-NPs used for some in vitro experiments contained no 
fluorophore to avoid interference of fluorescence spectra. Control (CTR): cells were incubated 
for 16 h with complete DMEM 1% FBS supplemented with the same volume of sterile H2O in 
which SiO2-NPs were dispersed. Subsequently, samples of both conditions were washed twice 
with warm phosphate-buffered saline (PBS) and analyzed after the treatment (Day 0) or after 
1, 4, 8 and 14 days of in vitro recovery in standard medium. H9C2 cell lines were purchased 
from the American Type Culture Collection and cultured in complete DMEM standard medium. 
Transmission electron microscopy 
High-resolution transmission electron microscopy (HR-TEM) images of SiO2-NPs in their bare 
form and after suspension in DMEM 1% FBS followed by washing with distilled water were 
obtained with a Jeol 3010 microscope operated at 300 kV. Specimens were prepared by 
suspending the samples in distilled water and depositing a drop of the suspensions on Cu 
grids coated with a lacey carbon film, waiting until dryness. 
For HR-TEM analysis, cells were prepared following procedures described by Raimondo et al. 
[21] See Supplementary for detailed explanation. 
Confocal microscopy 
hMSCs were seeded on 24-well ibiTreat microplate (Ibidi GmbH, Planegg, Germany) and, at 
the end of experiments, were processed for confocal immunofluorescence. Briefly, cells were 
fixed with 4% paraformaldehyde (PFA), permeabilized with 1% Triton-X-100 and blocked with 
6% (w/v) BSA and 2.5% (v/v) normal goat serum. 
For focal adhesion complex (FAC) analysis cells were stained for 2 h at room temperature 
(RT) with the primary antibody mouse anti-vinculin (Sigma-Aldrich) (1:600) and then incubated 
for 30 min at 37°C with the secondary antibody anti-mouse Alexa Fluor 488 (Thermo Fisher, 
MA, USA) (1:500). Quantification was performed evaluating at least 40 cells per sample using 
ImageJ® [22]. 
For Connexin-43 analysis, both permeabilized and nonpermeabilized cells were incubated for 
16 h at 4°C with the primary antibody mouse anti-Connexin-43 (1:400) and then the secondary 
antibody anti-mouse Alexa Fluor 488 (1:500) was added. Nuclear staining was performed with 
Hoechst-33342 (5 μg/ml). Quantification was assessed evaluating at least 120 cells per 
sample using ImageJ®. 
For LC3 analysis, permeabilized cells were incubated for 16 h at 4°C with the primary antibody 
rabbit anti-LC3 (1:200) and stained for 60 min at RT with the secondary antibody anti-rabbit 
Alexa Fluor 488 1:500 in PBS. 
To mark late endosomes and lysosomes, cells were incubated for 15 min at 37°C with 
LysoTracker Green (2 μmol/l) (Life Technologies, Italy) in complete DMEM and analyzed with 
inverted confocal laser scanning microscope LSM 800 (Carl Zeiss, Germany). 
Flow cytometry 
For Connexin-43 surface expression, approximately 400,000 hMSCs were trypsinized and 
maintained in 10% FBS culture medium for 2 h at RT, on a rocker platform to enable 
regeneration of the receptors. Cells were then washed with PBS, fixed 15 min at RT with 4% 
PFA, washed with PBS supplemented with 1% FBS and stained for 30 min at 4°C with rabbit 
polyclonal anti Connexin-43 primary antibody (Sigma-Aldrich) 1:60 in PBS, followed by 
incubation with secondary antibody goat anti-rabbit conjugated with phycoerythrin (PE, 
Southern Biotech, USA) 1:500 in PBS for 30 min at 4°C. Then cells were washed once with 
PBS, suspended in cold PBS, acquired with CyAN ADP flow cytometer (Beckman Coulter, CA, 
USA) and analyzed by Summit 4.3 software. At least 20,000 events per sample were 
collected. 
Cell adhesion & cell detachment assays 
For cell adhesion assay, cells were detached with 0.25% Trypsin-0.2% EDTA and 
resuspended in DMEM with 10% FBS in a 15 ml sterile tube to a final concentration of 
1 × 105/ml. Cells were maintained in rotation at RT for 2 h to allow surface receptor recovery. 
Then cells were spin down and resuspended at a final concentration of 2 × 105/ml. A 100 μl of 
cells’ suspension (2 × 104 cells) was then seeded in fibronectin (10 μg/ml) coated 96-well 
plates and cells were allowed to adhere for 5 or 15 min at 37°C in the CO2chamber. At least 
three wells were analyzed for each condition. The assay was stopped discarding the medium 
carefully without scratching the bottom of wells and rinsing cells once with PBS and washing 
three-times with 0.5% BSA in PBS. 
For cell detachment assay, cells were seeded in fibronectin (10 μg/ml) coated 96-well plates at 
a density of 10,000/cm2 and cells were allowed to adhere overnight at 37°C in the 
CO2 chamber. Cells were treated with either control medium or SiO2-NPs and then incubated 
with 0.025% Trypsin-0.02% EDTA for 4 or 8 min. The assay was stopped discarding the 
detached cells carefully without scratching the bottom of wells and rinsing cells once with 
DMEM 10% FBS and washing for three-times with PBS -0.5% BSA. 
For both assays, cells were then fixed with 4% PFA for 10 min at RT and washed with PBS. 
To quantify the amount of adherent cells 0.1% crystal violet was added to each well and 
incubated for 10 min at RT; after three washes with ddH2O (200 μl/well), the plates were let to 
dry up completely. Finally, 100 μl of 2% SDS were added to each well and incubated for 
10 min with gentle shaking at RT. Fluorescence emission (excitation filter: 485 ± 20 nm; 
emission filter: 535 ± 25 nm) was read with an Infinite F200 microplate reader (Tecan Group 
Ltd., Switzerland). 
Cell injection in ex vivo perfused infarcted rat hearts 
Perfusion of isolated rat hearts & injection of SiO2-NPs-hMSCs 
Experiments were performed on adult male Wistar rats (450–550 g body-weight) (n = 4). 
Animals were heparinized (2500 U im., Roche, Italy) and anaesthetized with urethane (1 g/kg 
ip.) 10 min later. The hearts were rapidly excised, cannulated via the aorta and retrogradely 
perfused with oxygenated Krebs-Henseleit buffer containing (in mmol/l) 127 NaCl, 17.7 
NaHCO3, 5.1 KCl, 1.5 CaCl2, 1.26 MgCl2 and 11 D-glucose, supplemented with 5 μg/ml 
lidocaine. A constant flow was adjusted with a proper pump (Watson-Marlow 313, UK) to 
obtain a typical coronary perfusion pressure of 80–85 mmHg during initial stabilization. 
Thereafter, the same flow level (9 ± 1 ml/min/g) was maintained throughout the experiment. 
The temperature of perfusate and hearts were kept constant at 37°C throughout the 
experiments. 
To produce an infarction, after 30-min stabilization, the left descending coronary artery was 
occluded for 30 min (Supplementary Figure 2, ‘Ischemia’, recognized by pale-colored tissue 
after coronary occlusion and by a fall in left ventricular developed pressure) and then re-
opened to full reperfusion of the left ventricle (Supplementary Figure 2, ‘Reperfusion’). Hearts 
were divided into two groups, one group received 5-chloromethylfluorescein diacetate 
(CMFDA)-treated and the other received red fluorescent cyanine dye-doped SiO2-NPs-treated 
hMSCs. A total of 1 × 106 cells were injected in the apex after 30 min of reperfusion. All the 
experiments were then stopped after total 6 h, as this time was considered the end point for 
proper ex vivo experiments, according to Penna et al. [23]. 
Heart processing & immunofluorescence analysis of tissue slices 
At the end of perfusion, atria and vasa were discarded and ventricles were fixed 3 h RT with 
4% PFA with gentle stirring. After four washes with PBS, tissues were submerged in PBS 
supplemented with 30% sucrose, allowed to precipitate overnight at 4°C and then incubated 
30 min RT in a solution 1:1 of 30% sucrose and TissueTek® Optimal Cutting Temperature 
(OCT™, Sakura FineTek, CA, USA). Finally, tissues were embedded in OCT and stored at -
80°C. Transverse slices 10 μm thick were obtained starting from the apex with a CM 1900 
cryostat (Leica Microsystems GmbH, Wetzlar, Germany) and processed.  Sections for 
ultrastructural analysis were processed for immunofluorescence. Briefly, they were rinsed in 
PBS, permeabilized 20 min at RT with 0.5% Triton-X-100 and blocked 1 h at RT with 6% 
wt/vol BSA and 2.5% NGS in PBS. The primary antibody mouse anti-sarcomeric α-actinin 
1:600 in PBS was incubated overnight 4°C and the secondary antibody anti-mouse Alexa 
Fluor 488 1:1000 in PBS was incubated 1 h at RT. After several washes with PBS, samples 
were finally mounted with Mowiol and conserved at 4°C. 
Dye transfer assay 
To monitor diffusion of fluorescent molecules through gap junctions (dye coupling) we used a 
method similar to the ‘parachute’ assay [24]. The method we used considered donors (hMSC 
cells – untreated or treated with SiO2–NPs) loaded with a gap junction permeant dye, in other 
words, Calcein-AM and unlabeled acceptors (cardiomyoblasts H9C2 cells). 
For confocal microscopy analysis, hMSCs were labeled with Calcein-AM (Sigma-Aldrich) 
membrane permeant dye (1 μM) for 30 min at 37°C. After labeling, the cells were cocultivated 
(hMSC:H9C2 ratio 1:2) for 6 h at 37°C and then analyzed for their fluorescence. The two cell 
types were distinguished morphologically. Carbenoxolone-disodium (Sigma-Aldrich) was used 
to inhibit Calcein-AM transfer through gap junctions. Cells were preincubated with the inhibitor 
(100 μM) overnight at 37°C. After labeling, the cells were cocultivated (hMSC:H9C2 ratio 1:2) 
for 6 h at 37°C and then analyzed for their fluorescence. The two cell types were distinguished 
morphologically. 
For flow cytometry analysis hMSCs were labeled with Calcein-AM in the same way as for 
confocal microscopy analysis. After labeling, hMSCs were cocultivated with H9C2 for 24 h at 
37°C and incubated with 21% O2 and 5% CO2, in other words, normoxia or in a hypoxic 
chamber with 1% O2 and 5% CO2, in other words, hypoxia. Before starting a coculture, H9C2 
intended for hypoxia were maintained for 150 min in 0% O2, 5% CO2, glucose-free medium to 
mimic ischemia as reported by Cselenyák et al. [25]. CD90 staining was performed using 
specific MSC marker anti CD90-PE antibody (BD Pharmingen, CA, USA) 1:10 in PBS for 
30 min at 4°C to distinguish hMSCs and H9C2. Cells were acquired with CyAN ADP flow 
cytometer (Beckman Coulter) and analyzed by Summit 4.3 software. At least 100,000 events 
per sample were collected. 
As a negative control, Vybrant®-5-(and-6)-carboxyfluorescein diacetate, succinimidyl ester 
(CFDA SE; Molecular Probes) labeled hMSCs were used. CFDA-SE is a fluorescein-based 
tracer. Once inside the cell, nonspecific esterases cut its lipophilic groups and the dye remains 
in the cell. The concentration of 2.5 μM in PBS was used for 15 min at 37°C. At least 20,000 
events per sample were collected. 
Cell metabolism 
To evaluate cell metabolism, CellTiter-Blue® (Promega, Leiden, the Netherlands) assay was 
used. See Supplementary Materials for more information. 
Western blot analyzes 
hMSCs were lysed with RIPA buffer and 12 μg of protein samples was loaded. SDS-PAGE 
(12% Bis-Tris gel, Invitrogen, CA, USA), Polyvinylidene difluoride  transfer membrane and 
quantification BCA assay (Thermo Scientific, MA, USA) were used. Membranes were blocked 
in 5% milk for 1 h at room temperature and probed with the primary antibodies (anti-LC3B, 
anti-p62/SQSTM1 purchased from Sigma-Aldrich) (1:1000) overnight at 4°C, followed by 
secondary antibodies (1:5000) for 1 h at RT. Bands were visualized using an enhanced 
chemiluminescence kit (SuperSignal™ West Pico PLUS, Thermo Scientific). 
Statistical analysis 
Data are expressed as a mean ± standard error of the mean (SEM) of at least three different 
experiments or as the mean ± standard deviation (SD) of representative experiments. 
Statistical comparisons were performed with either paired or unpaired Student's t-test. 
Differences with p < 0.05 were regarded as statistically significant. 
Results 
The state of SiO2-NPs when administered to cells and their efficient 
internalization by hMSCs 
For the administration of NPs to cells, an aliquot of the water suspension of NPs, where they 
were almost monodispersed (Figure 1A), was added to complete DMEM – 1% FBS, and this 
resulted in the formation of agglomerates of ca. 1 μm in size, stable over at least 1 h (Figure 
1B), in other words, a time corresponding to the incubation stage with cells inspected by HR-
TEM. It is worth mentioning that a protein corona was formed on NPs agglomerates when 
suspended in DMEM-1% FBS [17], that was possible to image for the very few small clusters 
of NPs found on the specimen grid when depositing a drop of NPs-DMEM 1% FBS 
suspension (Figure 1A & B). According to the formation of the protein corona, the ζ-potential of 
NPs changed in a large extent, passing from -25 to -9 mV for SiO2-NPs in the bare form and in 
DMEM 1% FBS, respectively (Figure 1A & B). Some agglomeration of NPs was retained 
during incubation with cells, as indicated by HR-TEM analysis, which allowed observing 
invaginations of the hMSC plasma membrane that surrounded ensembles of NPs, explainable 
as the beginning of an endocytic process (Figure 1C). 
Figure 1. Silica nanoparticle 
characterization and interaction with human mesenchymal stem cells. 
(A) Hydrodynamic radius (by dynamic light scattering) and ζ-potential (left panel) and TEM 
image (right panel) of silica-nanoparticle (SiO2-NP) dispersed in water. (B) Hydrodynamic 
radius (by dynamic light scattering) and ζ-potential (left panel) and TEM image (right panel) of 
SiO2-NP suspended for 1 h in complete medium supplemented with 1% fetal bovine 
serum. Arrow shows the corona formed by serum protein adsorbed on the NPs. Dotted circle 
represents the shape of NPs. (C) TEM images of human mesenchymal stem cells after 1 h of 
incubation with SiO2-NP in complete medium supplemented with 1% fetal bovine serum. 
Magnification 50,000×. 
TEM: Transmission electron microscopy; NP: Nanoparticle. 
The cytofluorimetric analysis confirmed that virtually all hMSCs possessed internalized NPs by 
the end of the treatment (16 h) (Supplementary Figure 1). 
SiO2-NP internalization modifies focal adhesion structure in hMSCs 
Adhesion is an essential process of anchorage-dependent cells involved in regulation of cell 
functions and indeed, in regenerative medicine, one crucial aspect concerns the capability of 
stem cells to interact with the surrounding environment. One of the earliest and best-
characterized adhesion structures are focal adhesion complexes, in other words, large 
macromolecular complexes that link the actin cytoskeleton to the ECM to provide traction, and 
properly regulated FAC dynamics are critical for cell attachment and migration [26–28]. 
To identify possible effects of SiO2-NP internalization on cellular FACs, we evaluated the 
universal focal adhesion marker vinculin [29,30] by immunofluorescence and confocal 
microscopy analysis. Qualitative evaluation of images strongly suggested that, following SiO2-
NP internalization, FACs acquired a more elongated shape and an increased size (Figure 2A). 
FAC analyzes showed that after SiO2-NP internalization the total number of FA remained 
unchanged, yet their mean size was significantly increased (Figure 2B & C). Considering the 
growth model of force-induced focal adhesion driven by actomyosin-mediated tension [26,31], 
large focal adhesions tend to be elongated, while small focal adhesions tend to be round. FAC 
length and width measurements showed that in control hMSCs a low length/width ratio 
occurred more frequently, indicative of a prevalently round structure, while in SiO2-NP-hMSCs 
a high length/width ratio was prevalent, indicating an elongated structure (Figure 2D & E). 
Figure 2. Silica 
nanoparticle effects on human mesenchymal stem cell focal adhesion complexes. 
Cells were treated for 16 h with either control medium (CTR) or silica nanoparticles (SiO2-NPs) 
and then stained with an anti-vinculin antibody conjugated with a green fluorophore before 
confocal microscopy acquisition. (A)Representative confocal images of stained cells shown 
the qualitative differences of the FACs. Magnification 63×. (B & C) Quantification of the 
number of FACs/cell (B) and FAC mean area (C) in CTR and SiO2-NP treated human 
mesenchymal stem cells (hMSCs). Data are shown as mean ± standard deviation 
(SD). (D) Quantification of the FAC elongation distribution (expressed as %) in CTR and SiO2-
NP treated hMSCs. FA elongation index was obtained calculating the length/width ratio of 
every FA. (E) Quantification of FAC elongation in CTR and SiO2-NPs treated hMSCs. Data are 
shown as mean ± SD. 
*p < 0.05; **p < 0.01. 
FAC: Focal adhesion complex. 
These data, taken together, demonstrate that SiO2-NP treatment increases hMSC FAC area 
and elongation, suggesting the possibility that SiO2-NP internalization induces FAC 
stabilization contributing to confer an enhanced capability of SiO2-NP treated hMSCs to adhere 
to a substrate [32]. 
SiO2-NP internalization augments hMSC adhesion behavior in vitro & ex vivo 
The adhesive strength of SiO2-NP-hMSCs was assessed using two different in vitro assays. 
One was the trypsin/EDTA-induced detachment assay, which measures the strength of cell 
attachment to fibronectin (FN)-coated plates. FN was used as it is an important component of 
cardiac ECM and it is strongly up-regulated in vivo after myocardial infarction [33]. After 
treatment with trypsin/EDTA, SiO2-NP-hMSCs remained attached to the plate at a significantly 
higher level than control hMSCs after 4 and 8 min (Figure 3A). 
Figure 3. Silica 
nanoparticles effect on human mesenchymal stem cell adhesion. 
(A) Trypsin-based cell detachment assay. Control (CTR) and silica nanoparticle-human 
mesenchymal stem cells (SiO2-NP-hMSCs) were treated with 0.025% trypsin-0.02% EDTA for 
the indicated time points. The ability of hMSCs to remain attached to the substrate was 
evaluated. (B) Adhesion assay. CTR and SiO2-NP-hMSCs were allowed to adhere on 
fibronectin coated plates for the indicated time points. For both assays (A & B), adherent cells 
were stained with 0.1% crystal-violet and their relative absorbance was determined 
spectrophotometrically at 540 nm. Data are shown as mean ± standard deviation. (C) Imaging 
of CMFDA-labeled hMSCs inside infarcted hearts. (D) Imaging of red fluorescent cyanine dye-
doped SiO2-NPs-labeled hMSCs inside infarcted hearts. For both images (C & D), 
reconstruction of a 10 μm transverse slice to show the distribution of labeled hMSCs in 
infarcted hearts. Green/Red points put to highlight the clusters of hMSCs. Magnification 10×, 
scale bar 200 μm. (E & F)Superposition of sarcomeric α-actinin staining (red in E and green 
in F) and labeled hMSCs (green with CMFDA in E and red with SiO2-NPs in F). Magnification 
20×. **p < 0.01; ***p < 0.005. 
CMFDA: 5-chloromethylfluorescein diacetate. 
Another technique used was the adhesion assay, which measures the adhesion of hMSCs 
that have been allowed to attach on FN-coated plates. Results showed an increased adhesion 
of SiO2-NP-hMSCs in comparison to control cells. After 5 and 15 min of adhesion on FN-
coated plates, the presence of SiO2-NPs conferred a significantly higher ability to adhere to the 
substrate (Figure 3B). 
We next assessed the possibility to highlight an increased adhesion behavior following SiO2-
NP internalization in the challenging condition of a beating heart, subjected to 
ischemia/reperfusion (I/R). To this aim, an ex vivo model of perfused rat heart was used and 
cells were injected into the apex 30 min after the ligation of left descending coronary artery 
was removed (Supplementary Figure 2). Cells employed for these investigations were 
exposed for 16 h to SiO2-NPs and then immediately injected; as a control, we used hMSCs 
labeled with the CMFDA green fluorescent probe, a well-known labeling procedure commonly 
used to highlight cell integration in vivo and that does not interfere with hMSC adhesion 
properties (our data not shown). Reconstruction of a representative transverse section 
highlighted that SiO2-NP labeled cells were clearly visible and widespread distributed inside 
the walls of both right and left ventricles (Figure 3C). Differently, few CMFDA labeled cells can 
be detected (Figure 3D). These findings are confirmed with a higher amplification and α-actinin 
immunostaining (Figure 3E & F). 
These results demonstrate that SiO2-NP internalization confers increased adhesion ability to 
hMSCs both in vitro and ex vivo. 
SiO2-NP internalization enhances Connexin-43 surface expression & favors the 
communication between hMSCs & cardiac myoblasts 
In the context of cardiac regenerative medicine, it is necessary that hMSCs form gap junctions 
with the surrounding cells, to become an effective member of the myocardium [11]. As Cx43 is 
the most important gap junction complex in the myocardium, we investigated whether SiO2-
NPs internalization by hMSCs could affect Cx43 expression. Surface expression of Cx43 was 
first evaluated by flow cytometry analysis. Control cells were positive for Cx43, presenting a 
homogenous, low level of fluorescence. After SiO2-NPs treatment, fluorescence relative to 
Cx43 increased significantly, indicating an increase in Cx43 surface membrane expression 
(p < 0.001) (Figure 4A). These data were confirmed by confocal microscopy analysis. 
Qualitative observation of confocal images suggested that the dot-like expression of Cx43 was 
increased in SiO2-NPs treated hMSCs (Supplementary Figure 3). Quantification of the total 
area of the Cx43 confirmed that following SiO2-NPs internalization hMSCs significantly 
increased Cx43 expression (Figure 4B). 
Figure 4. Silica nanoparticles effect 
on human mesenchymal stem cell intercellular communication. 
(A) Box plot showing the distribution of the median fluorescence relative to Cx43 in control 
(CTR) and silica nanoparticles (SiO2-NPs) treated human mesenchymal stem cells (hMSCs) 
(eight independent experiments) obtained by flow cytometry. Paired t-test were performed 
***p < 0.001. (B) Box plot showing the quantification of Cx43 area in CTR and SiO2-NPs 
treated hMSCs obtained by confocal microscopy. At least 120 cells were analyzed. Unpaired t-
test was performed. ****p < 0.0001. One representative experiment out of 
three. (C) Representative dye transfer image in confocal microscopy. hMSCs were labeled 
with Calcein-AM (green cells) without (top panel) or in presence (lower panel) of the gap 
junction inhibitor Carbenoxolone and H9C2 were discriminated morphologically by phase 
contrast images. Cells were cocultured for 24 h and the presence of H9C2 cells that received 
Calcein-AM through intercellular communication with hMSCs were detected as green color in 
H9C2 cells. (D) Representative dye transfer experiment in flow cytometry. Upper panel: H9C2 
cells were cultured for 24 h alone (white histogram) or in the presence of either CTR (light gray 
histogram) or SiO2-NP treated hMSCs (black histogram) labeled for 24 h with Calcein-AM (gap 
junction permeant dye). The green fluorescence detected in H9C2 cells was due to the 
Calcein-AM they received through intercellular communication with hMSCs. Lower 
panel: H9C2 cells were cultured for 24 h alone (white histogram) or in the presence of either 
CTR (light gray histogram) or SiO2-NPs treated hMSCs (black histogram) labeled for 24 h with 
CFDA-SE (gap junction impermeant dye). The absence of H9C2 cells that received CFDA-SE 
was verified. H9C2 and hMSCs were distinguished through CD90 hMSC specific surface 
marker. (E) Box plot showing the distribution of the mean fluorescence relative to Calcein-AM 
that H9C2 received from CTR (black borders) and SiO2-NPs treated hMSCs (gray borders) 
obtained by flow cytometry. At least 80,000 cells were analyzed for each experiment. Data 
were normalized on control cells in normoxia. T-test was performed. *p < 0.05. 
These data show that SiO2-NP treatment induces the surface expression of gap junction Cx43 
protein, suggesting the interesting possibility that SiO2-NP-hMSCs might have an increased 
capability to communicate with the surrounding cells. To demonstrate this hypothesis, gap 
junction-mediated dye transfer assays between SiO2-NP-hMSCs and the cardiomyoblast H9C2 
cell line were performed. hMSCs were labeled with the gap junction permeant dye Calcein-AM 
or the gap junction impermeant dye CFDA-SE and cocultured with unlabeled H9C2 cells. 
Transfer of Calcein-AM between hMSCs and H9C2 cells was observed in confocal microscopy 
(Figure 4C, upper panel) and it was blocked when a gap junction inhibitor was added, as 
expected (Figure 4C, lower panel). Analysis of cocultures by flow cytometry demonstrated that 
H9C2 cells gained Calcein-AM from hMSCs while no CFDA-SE was transferred, 
demonstrating that gap junction intercellular communication occurs between these cells. 
(Figure 4D). After SiO2-NP treatment, hMSCs increased the amount of Calcein-AM transferred 
to H9C2 cells, in both, normoxia and hypoxia, demonstrating the correct functionality of the 
enhanced surface Cx43 expression. (Figure 4E). The increment of dye exchange between 
CTR and SiO2-NP-hMSCs was statistically significant in both, normoxic and hypoxic 
conditions. It was also evident that more dye was exchanged in hypoxia than in normoxia, 
although not in a statistically significant way. (Figure 4E). 
Transient lysosomal degradation impairment induced by SiO2-NP uptake could 
explain the observed functional effects on hMSCs 
In order to find a possible explanation for the observed functional effects, we focused our 
attention on the mechanism of intracellular accumulation of SiO2-NPs. Internalized SiO2-NPs 
displayed a punctuate distribution with some enrichment in the perinuclear area, suggestive of 
their accumulation within intracellular organelles. We previously demonstrated that while no 
colocalization of internalized SiO2-NPs with the Golgi complex, mitochondria or the 
endoplasmic reticulum was detected, the accumulation of SiO2-NPs in late 
endosomes/lysosomes was clearly observed in living cells incubated with LysoTracker Green, 
an organic heterotricyclic 4-bora-3a,4a-diaza-s-indacene compound that accumulates within 
the acidic lumen of late endosomes/lysosomes [16,18]. In accordance with our previously 
published results, LysoTracker staining of living cells highlighted that untreated hMSCs 
prevalently displayed few and small lysosomes around nuclei, while hMSCs exposed to SiO2-
NPs presented a greater number of larger organelles, most of which were perinuclear (Figure 
5A – day 0). A time course analysis of LysoTracker experiments on SiO2-NP-treated hMSCs 
highlighted that at 1 and, to a lesser extent, 4 days after the treatment larger organelles were 
still observed (Figure 5A – days 1 and 4). However, after 8 days of culture hMSCs displayed a 
normalized lysosome compartment, demonstrating that lysosomal compartment perturbation is 
a transient event induced by NP accumulation that can be spontaneously recovered by 
hMSCs (Figure 5A – day 8). Accordingly, no metabolic impairment was observed in SiO2-NP 
treated hMSCs up to 8 days, as evaluated through a fluorometric assay (Figure 5B). We next 
investigated whether the phenotypic changes observed in SiO2-NP treated hMSCs are 
maintained over time or are transient, analogously to lysosomal accumulation. Interestingly, 
we found that both increased cell adhesion and Cx43 expression returned to baseline levels in 
parallel with lysosomal compartment normalization (Figure 5C & D). Further, we found that 
inhibition of lysosomal degradation activity, obtained using 100 nM bafilomycin A1 for 2 h, 
reproduced in CTR hMSCs both, increased adhesion and Cx43 expression observed in SiO2-
NP-treated cells (Figure 6A & B). This suggested that SiO2-NP-filled lysosomes might be 
transiently impaired in their degradation activity. 
Figure 5. Time 
course, metabolism and phenotype analysis of silica nanoparticles effects on human 
mesenchymal stem cells. 
(A) Control (CTR) and silica nanoparticles (SiO2-NP) treated human mesenchymal stem cells 
(hMSCs) were labeled with LysoTracker (green) at day 0 – day 1 – day 4 – day 8 time points 
and representative images were acquired by confocal microscopy. Magnification 
63×. (B) CellTiter-Blue fluorescence were analyzed at day 0 – day 1 – day 4 – day 8 and the 
fluorescence values were normalized on control cells and represented as mean ± standard 
deviation (SD). (C) CTR and SiO2-NP treated hMSCs were allowed to recover in complete 
medium for 4, 8 and 14 days and then adhesion assay was performed after 5 min of adhesion. 
Adherent cells were stained with 0.1% crystal-violet and their relative absorbance was 
determined spectrophotometrically at 540 nm. Data are shown as mean ± SD; 
*p < 0.05. (D) CTR and SiO2-NP treated hMSCs were allowed to recover in complete medium 
for 1, 4 and 8 days and then Cx43 expression was evaluated by confocal microscopy. Box plot 
showing the quantification of Cx43 area in CTR and SiO2-NPs treated hMSCs. At least 120 
cells were analyzed. Unpaired t-test was performed. **p < 0.01. 
Figure 6. Inhibition of lysosomal 
degradation activity. 
(A) Adhesion assay. Human mesenchymal stem cells (hMSCs) were treated for 2 h with either 
control medium or Bafilomycin A1 100 nM. Cells were allowed to adhere on fibronectin coated 
plates for the indicated time points. Adherent cells were stained with 0.1% crystal-violet and 
their relative absorbance was determined spectrophotometrically at 540 nm. Data are shown 
as mean ± standard deviation (SD); ***p < 0.001, ****p < 0.0001. (B) hMSCs were treated for 
2 h with either control medium or Bafilomycin A1 100 nM and then Cx43 expression was 
evaluated by confocal microscopy. Unpaired t-test was performed. Data are shown as 
mean ± SD; ***p < 0.001. (C) Control (CTR) and silica nanoparticle (SiO2-NP) treated hMSCs 
were analyzed by western blotting for p62 and LC3. The level of p62 and the LC3-II/LC3-I ratio 
were quantified and normalized to untreated control cells. Data are shown as mean ± SD; 
*p < 0.05, ***p < 0.001. (D) Left, representative confocal images of CTR or SiO2-NP treated 
hMSCs incubated in conditions as above. After fixation, cells were stained for LC3. Right, 
quantification of LC3 puncta per cell. Data are shown as mean ± SD; ***p < 0.001, 
****p < 0.0001. (E) Left, representative confocal images of SiO2-NP treated hMSCs stained 
with LC3 and/or LysoTracker green. Right, Pearson's correlation analyzes showing near 
complete lack of colocalization between LC3 and LysoTracker (0.223 ± 0.172), and strong 
colocalization between SiO2-NPs and LysoTracker (0.909 ± 0.255). Data are the mean ± SEM, 
n = 3 independent experiments. 
Considering that bafilomycin A1, a widely used inhibitor of autophagosome–lysosome fusion in 
vitro to determine the activity of autophagic flux, reproduced the phenotype of SiO2-NP treated 
cells, we addressed the hypothesis that altered lysosomal degradation might result from 
impaired cargo delivery to SiO2-NP-filled lysosomes from upstream donor compartments, such 
as autophagosomes. If this were the case, one would expect that autophagosomal 
components, like LC3-II and p62, being substrates for lysosomal proteolysis, accumulate in 
SiO2-NP treated cells and they do so in compartments (autophagosomes) lacking SiO2-NPs 
(accumulated in lysosomes), due to impaired autophagosome–lysosome fusion. In accordance 
with this hypothesis, WB analysis indicated a transient cellular accumulation of both LC3-II and 
p62 proteins in SiO2-NP treated cells that peaked at 1 day and began to attenuate at 4 days 
(Figure 6C). Further, confocal imaging revealed that starvation of control cells resulted in 
increased levels of LC3 due to the accumulation of LC3-positive autophagosomes, and this 
phenotype was exacerbated by concomitant application of bafilomycin to prevent lysosomal 
turnover of autophagosomes (Figure 6D, upper panel); cells treated with SiO2-NPs, instead, 
displayed high levels of LC3 and accumulated LC3-positive autophagosomes largely 
irrespective of whether cells had been starved and/or treated with bafilomycin (Figure 6D, 
lower panel). Finally, a near complete lack of colocalization between LC3 and SiO2-NP-filled 
lysosomes (e.g., positive for LysoTracker) was revealed (Figure 6E). Altogether, these data 
strongly indicated an NP-induced transient impairment of autophagic flux as a likely 
mechanistic explanation. 
Discussion 
While NP-based stem cell imaging is an essential tool for regenerative medicine, cellular 
uptake of NPs might trigger numerous intracellular signaling events through which cells control 
their function and state. The central aim of this work was to evaluate any possible functional 
effects of SiO2-NPs on hMSC therapeutic potential, with particular emphasis on cardiac 
regeneration and interaction with the cardiac environment. The data collected here suggest 
that SiO2-NP internalization does have an influence on hMSC cell behavior, providing strong 
evidence that nanostructures not only passively interact with cells but also actively engage and 
mediate the molecular processes that are essential for regulating cell functions. 
First, we found that SiO2-NP treatment is associated with significant changes in focal adhesion 
structures. In particular, the FACs of SiO2-NP treated hMSCs are increased in mean area and 
elongation index as evidenced by vinculin staining. This biological effect seems not to be 
peculiar of SiO2-NPs, however, as interestingly, Tay and collaborators obtained similar results 
by examining vinculin surface expression in TR146 oral mucosa cells treated with SiO2, 
TiO2 and hydroxyapatite NPs [34]. The higher occurrence of long mature FACs near cell–cell 
boundaries was detected through vinculin immunofluorescence analysis, suggesting the 
promotion of an increased adhesive phenotype [34]. In this work, we describe this phenotype 
for the first time in hMSCs. 
These findings made it plausible to hypothesize an increased adhesion capability of hMSCs 
due to SiO2-NP treatment, which was confirmed using in vitro and ex vivo models. While an 
increased in vitro cell adhesion was previously described in MSCs treated with other NP types 
(metal oxide NPs), we here document for the first time an augmented engraftment of SiO2-NP 
treated hMSCs in the myocardial tissue upon injection in infarcted isolated rat hearts. 
Considering that adhesion of the transplanted hMSCs is necessary not only for cell 
engraftment and generation of new tissue but also for a cross-talk between transplanted cells 
and receiving an organ, our data suggest the possibility that the internalization of a SiO2-NP 
stimulates a cell function (engraftment) that is required for an effective regenerative therapy. 
Using non-NP-based, ex vivogenetic modification approaches, several studies demonstrated 
that an increased adhesion phenotype of MSCs represents a crucial aspect to enhance cell 
survival and therapeutic potency upon transplantation to sites of injury [35,36]. MSCs derived 
from transgenic rats overexpressing tissue transglutaminase, a coreceptor for FN implicated in 
cell adhesion associated with integrins [37], displayed enhanced cell attachment and 
spreading features. In these cells, the formation of FACs and the increased phosphorylation of 
the focal adhesion-related kinases PI3K and Src were observed. Moreover, the implantation of 
tissue transglutaminase-transfected MSCs in rat infarcted myocardium improved cardiac 
functions [38]. Other studies demonstrated that an increased adhesion phenotype enhances 
cell survival and prevents anoikis [38–40]. In particular, MSC transfection with an integrin-
linked kinase, a Ser/Thr kinase that interacts with the cytoplasmic domain of β1 integrin, plays 
a crucial role in ECM assembly, cell spreading, integrin-mediated cell adhesion, signaling and 
survival [41]. 
Further, we showed that SiO2-NP treatment increases Cx43 surface expression in hMSCs and 
dye transfer experiments demonstrated the functionality of these gap junctions and the 
possibility to increase intercellular communication with cardiomyoblasts. Increased Cx43 
expression suggests that hMSCs might readily integrate into electrical syncytia of cardiac 
tissue, promoting repair or serving as the substrate for a therapeutic delivery system. After 
acute myocardial infarction, severe loss of healthy myocardium impairs intercellular 
communications in the peri-infarct area and induces cardiac conduction disturbances [42,43]. 
Administration of naive MSCs at this phase may pose arrhythmic risks [44,45]. Previous 
studies addressed that abnormal cardiac conduction and arrhythmogenic remodeling after MI 
could be worsened by low Cx43 expression of naive MSCs [45,46]. Besides the use of NPs, 
growth factor (FGF-2, IGF-1, BMP-2) treatment of MSCs has been reported to augment 
intercellular connections with host cardiomyocytes via Cx40- and Cx43-mediated junctions 
[47]. Another study demonstrated that Ang II pre-treatment enhanced MSC gap junction 
protein expression in vitro [10]. Interestingly, injection of genetically modified MSCs that 
overexpressed Cx43 conferred a better reparative effect of the postinfarcted myocardium [46–
48]. Previous studies also showed that overexpression of Cx43 in MSCs can greatly improve 
the therapeutic efficacy of the cell therapy in MI regardless of the cellular arrangement of Cx43 
[46–49]. 
A possible effect of NPs on cellular gap junction crosstalk has been recently reported by Han 
and colleagues [50], although not in MSCs. Those authors demonstrated that iron oxide NPs 
significantly augmented the expression of Cx43 in H9C2, which would be critical for gap 
junctional communication with MSCs in coculture for the generation of therapeutic potential-
improved MSCs [50]. MSCs cocultured with iron oxide NP-harboring H9C2 cells showed active 
cellular crosstalk and displayed significantly higher levels of electrophysiological cardiac 
biomarkers and a cardiac repair-favorable paracrine profile, both of which are responsible for 
MI repair [50]. Our results, together with the above study, highlight an effect of NPs in 
developing gap junctional crosstalk among cells, extending the potential application of NPs in 
cell biology and stem cell-based therapies. Furthermore, this is a first study that shows an 
increase of Cx43 in hMSCs induced by SiO2-NPs internalization. 
What might be the reason for the two observed biological effects in hMSCs? After 
internalization, SiO2-NPs readily accumulate in lysosomes, and this might transiently impact on 
the lysosomal function. Based on the results we obtained in this work, including the 
spontaneous normalization of the biological phenotypes by 8 days from SiO2-NP treatment, a 
time when normalization of lysosomal compartment could also be described, and the capability 
of reproducing the same biological effects by the use of a lysosomal activity inhibitor that 
impedes autophagosome–lysosome fusion, our conclusion is that accumulation of SiO2-NPs in 
lysosomes cause a transient block of autophagic flux in hMSCs. In accordance, we found an 
accumulation of two autophagosome marker proteins, LC3-II and p62, in SiO2-NP treated cells 
and a near complete lack of colocalization between LC3 and SiO2-NP-containing lysosomes. 
Accumulation of SiO2-NPs in lysosomes is thus predicted to result in transient inhibition of 
autophagy-mediated protein turnover in hMSCs, leading to perturbed degradation of cytosolic 
proteins, in perfect accordance with two recently published papers concerning lysosomal 
dysfunction caused by silica NPs [51,52]. Indeed, cell adhesion is one of the cellular 
processes described to be regulated by autophagy [53,54] and, early on in connexin research, 
it became clear that lysosomal pathways also contributed to the connexin degradation [55,56]; 
more recently, autophagy has emerged as a crucial connexin-degradation pathway for 
different connexin isoforms, including Cx-43 [57]. Notably, this transient dysfunction in 
lysosomal activity occurs in complete absence of any metabolic impairment or cytotoxicity in 
our cells, at variance with what has been reported for human cervix carcinoma cells [51] and 
human hepatocytes [52]. Lysosomal activity inhibition is subsequently overcome in hMSCs 
presumably due to SiO2-NP distribution to daughter cells and their consequent intracellular 
dilution [18], and the phenotypic effects released in parallel. 
Conclusion 
The data presented in this work suggest that SiO2-NPs should no longer be viewed as simple 
imaging agents for biomedical applications, but can also play an active role in mediating 
biological effects, some of which might ultimately result in an augmented stem cell engraftment 
potential. Considering, in particular, the modified microenvironment due to a myocardial 
infarction, which includes ischemia, inflammation and anoikis, where substrate adhesion and 
early intercellular communication abilities of the transplanted hMSCs are potentially the major 
contributors to cell engraftment and tissue regeneration, the observed positive SiO2-NP 
functional effects may represent a desirable biological improvement. 
Future Perspective 
Increased adhesion and engraftment of stem cells in the damaged myocardium as well as 
enhancement of functional gap junctions in stem cell plasma membrane due to interaction with 
lysosomal activity are interesting effects of NP internalization in human mesenchymal stem 
cells. NPs could represent a feasible tool to overcome some important limitations of stem cell-
based therapies such as the low percentage of surviving and engrafted cells as well as the 
enhanced occurrence of arrhythmias in the injured cardiac tissue. Further study is needed to 
better understand whether NP internalization could influence also other aspects of stem cell 
behavior. 
Summary points 
 The therapeutic potential of human mesenchymal stem cells (hMSCs) in regenerating 
injured cardiac tissue is limited due to a low survival rate within the first week after 
transplantation. 
 To enhance transplanted cell survival, adhesion capacity and interaction with the 
surrounding cells in the injured tissue should be improved. 
 The aim of the present work was to evaluate whether any phenotypic effects could be 
exerted by internalization of silica nanoparticles (SiO2-NPs) that might ultimately impact 
on the interaction of hMSCs with the cardiac environment. 
Results 
 SiO2-NP internalization impacted hMSC focal adhesion complexes, thus increasing in 
vitroadhesion capacity and engraftment in the myocardial tissue upon cell injection in 
infarcted isolated rat hearts. 
 Furthermore, SiO2-NP treatment enhanced hMSC expression of Connexin-43, favoring 
hMSC interaction with cocultured cardiac myoblasts in an ischemia-like environment. 
 SiO2-NPs affected lysosomal function by causing transient inhibition of 
autophagosome–lysosome fusion. 
Conclusion 
 Besides the use of NPs as simple imaging agents for biomedical applications, they 
should be considered for playing an active role in mediating biological effects, some of 
which might ultimately result in an augmented stem cell engraftment potential. 
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